Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing minor surgery under local anesthesia who have ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
Exclusion criteria: Patients with known allergies or sensitivity to gabapentin. Regular gabapentin use within the past 1 month or previous treatment with gabapentin Substance Abuse and any known allergy to pain-killers including NSAIDs and opioids. Participants who are pregnant, lactating, or planning to conceive during the study. Patient with hepatic or renal impairment Any history of a pre-existing seizure or major psychiatric disorder. Patients taking antidepressants or anti-convulsant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS (Visual Analogue Scale),NRS (Numeric Rating scale), Requirement of analgesic or opioids perioperatively Timepoint: 2, 4-, 6-, 12-hours post-surgery and peri-operative | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient-reported side effects of the interventional drug, Gabapentin. (Treatment emergent side effects). Time for first analgesic or opioid requirement on patients requestTimepoint: 2, 4-, 6-, 12-hours post-surgery | — |
Countries
India
Contacts
Surgiderma Hospital